Actual medication label and appearance may vary
Peptide Treatment
BPC-157 Oral
Choose a treatment option
BPC-157 (Body Protection Compound-157) is a synthetic peptide fragment derived from a naturally occurring protein in human gastric juice. Unlike most peptides, it shows stability in stomach acid, which may allow some biological activity when taken orally. Research has explored its potential to support gut health, tissue repair, and systemic anti-inflammatory effects, though human data remain limited.
Check eligibilityBPC-157 is not FDA-approved to diagnose, treat, cure, or prevent any disease or medical illness.
Why it works
Key benefits
- Promotes healing of stomach and intestinal lining (ulcers, gastritis, leaky gut)
- Reduces inflammation in gut and connective tissues
- May support recovery from musculoskeletal or inflammatory injury
- Enhances gut-brain communication and microcirculation (animal data)
Based on preclinical research
Mechanism
How it works
Animal and cell studies suggest oral BPC-157 acts locally within the gastrointestinal tract, promoting mucosal healing, angiogenesis, and protection against oxidative stress. It may also trigger indirect systemic effects through enteric nervous system signaling and modulation of nitric oxide pathways.
Frequently asked questions
FAQs
Reported effects (anecdotally) may include improved digestion, reduced bloating, and better recovery tolerance within 1–3 weeks. Effects vary significantly depending on underlying inflammation and formulation quality.
Generally well tolerated. Occasional nausea or mild fatigue have been reported.
Before you begin
Informed Consent & Safety
No severe adverse events in available animal models, but human safety data are sparse. Avoid during pregnancy or if you have active cancer due to its angiogenic potential.
Research & Studies
Evidence at a Glance
- 1.
Sikiric P et al. Pharmaceuticals (2023). Reviews oral stability and GI repair activity.
- 2.
Gajovic S et al. Front Pharmacol (2023). Summarizes animal data for oral and injectable routes.
- 3.
Skutek M et al. Pharmaceutics (2024). Multifunctionality, angiogenic mechanisms, toxicity overview.
Interested in BPC-157 Oral?
Take a short assessment and a licensed provider will review if this treatment is right for you.
Clinical Guidance Disclaimer
The information provided in this document is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. It should never replace sound clinical judgment or personalized advice of a qualified healthcare professional. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment protocol. Never disregard professional medical advice or delay in seeking it because of something you have read in these materials.
Liability & Indemnification
By utilizing this information, the user acknowledges and agrees that REBL and its affiliates, providers, and staff are not liable for any direct, indirect, or consequential damages resulting from the use or misuse of the information provided herein. Any reliance on the materials contained in this document is solely at the user's own risk.
Regulatory Status
BPC-157 is an investigational peptide and not FDA-approved for any medical use. Commercially available oral products vary widely in quality and concentration.
Proprietary Rights & Use Restrictions
This document and its contents are the proprietary property of REBL. Unauthorized use, duplication, reproduction, or distribution of these materials—in whole or in part—without express written consent is strictly prohibited.